1. Home
  2. DCTH vs ASPN Comparison

DCTH vs ASPN Comparison

Compare DCTH & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • ASPN
  • Stock Information
  • Founded
  • DCTH 1988
  • ASPN 2001
  • Country
  • DCTH United States
  • ASPN United States
  • Employees
  • DCTH N/A
  • ASPN N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • ASPN RETAIL: Building Materials
  • Sector
  • DCTH Health Care
  • ASPN Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • ASPN Nasdaq
  • Market Cap
  • DCTH 630.4M
  • ASPN 570.6M
  • IPO Year
  • DCTH N/A
  • ASPN 2014
  • Fundamental
  • Price
  • DCTH $16.30
  • ASPN $5.69
  • Analyst Decision
  • DCTH Strong Buy
  • ASPN Strong Buy
  • Analyst Count
  • DCTH 4
  • ASPN 10
  • Target Price
  • DCTH $24.00
  • ASPN $21.78
  • AVG Volume (30 Days)
  • DCTH 610.5K
  • ASPN 2.8M
  • Earning Date
  • DCTH 05-08-2025
  • ASPN 05-08-2025
  • Dividend Yield
  • DCTH N/A
  • ASPN N/A
  • EPS Growth
  • DCTH N/A
  • ASPN N/A
  • EPS
  • DCTH N/A
  • ASPN N/A
  • Revenue
  • DCTH $53,850,000.00
  • ASPN $436,921,000.00
  • Revenue This Year
  • DCTH $141.47
  • ASPN N/A
  • Revenue Next Year
  • DCTH $49.31
  • ASPN $25.65
  • P/E Ratio
  • DCTH N/A
  • ASPN N/A
  • Revenue Growth
  • DCTH 1068.87
  • ASPN 51.90
  • 52 Week Low
  • DCTH $6.33
  • ASPN $4.16
  • 52 Week High
  • DCTH $18.23
  • ASPN $33.15
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 58.68
  • ASPN 46.45
  • Support Level
  • DCTH $15.73
  • ASPN $5.94
  • Resistance Level
  • DCTH $17.29
  • ASPN $6.92
  • Average True Range (ATR)
  • DCTH 0.96
  • ASPN 0.46
  • MACD
  • DCTH -0.08
  • ASPN -0.01
  • Stochastic Oscillator
  • DCTH 50.58
  • ASPN 23.51

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

Share on Social Networks: